Related Experiment Videos
Eight years' experience with the Medtronic-Hall valve prosthesis
J L Vallejo1, J M Gonzalez-Santos, J Albertos
1Department of Cardiac Surgery, General Hospital Gregorio Marañon, School of Medicine, Universidad Complutense, Madrid, Spain.
The Annals of Thoracic Surgery
|September 1, 1990
Summary
The Medtronic-Hall heart valve prosthesis shows excellent clinical performance with a low rate of complications over 8 years. This study confirms its reliability for patients with rheumatic valve disease.
Area of Science:
- Cardiovascular Surgery
- Biomaterials Science
- Clinical Outcomes Research
Background:
- Rheumatic valve disease is a significant cause of heart valve dysfunction.
- Mechanical heart valve prostheses are widely used for valve replacement surgery.
- Long-term data on specific valve models are crucial for clinical decision-making.
Purpose of the Study:
- To evaluate the long-term clinical performance of the Medtronic-Hall heart valve prosthesis.
- To assess the incidence of valve-related complications after implantation.
- To determine the survival rates associated with this prosthetic valve.
Main Methods:
- A retrospective analysis of 444 Medtronic-Hall valve implantations between January 1981 and September 1986.
- Inclusion of patients with various valve diseases, primarily rheumatic.
- Follow-up data collected for up to 8 years, with 97.7% completeness.
Main Results:
- Hospital mortality was 6.2%.
- The 8-year actuarial survival rate was 77.2%.
- Low linearized incidences of valve-related complications were observed, including thromboembolism (1.5%/patient-year) and reoperation (1.5%/patient-year).
Conclusions:
- The Medtronic-Hall valve prosthesis demonstrates excellent clinical performance and durability.
- Valve-related complications are within a low range, with no structural failures reported.
- The prosthesis is a reliable option for patients requiring heart valve replacement.